Eli Lilly's (LLY) cease-and-desist letter is dismissed by weight loss drug compounder, OrderlyMeds. Read more here.

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

The Düsseldorf court’s decision offers an instructive perspective on the legal nature of patent pledges as well as a reminder ...

U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

As demand soared for weight-loss drugs, price signals worked.

Eli Lilly says Indianapolis-based Premier Weight Loss is cracking open auto-injector pens containing its blockbuster drug and ...

The Michigan Supreme Court, after hearing oral arguments last year on the state attorney general’s desire to investigate Eli ...

The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on ...

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.